How much funding has Xtuit raised?

Xtuit has raised $22.0M in total funding, most recently a Series A round.

Who are Xtuit's investors?

Xtuit's investors include New Enterprise Associates, Polaris Partners, CTI Life Sciences Fund, Arcus Ventures, Omega Funds.

Where is Xtuit headquartered?

Xtuit is headquartered in Waltham, Massachusetts, United States.

What industry is Xtuit in?

Xtuit operates in Biotech, Healthcare.

Xtuit

Targeting the tumor microenvironment to overcome cancer drug resistance

Waltham, United States · Founded 2011 · $22.0M raised

Biotech

Healthcare

Headquarters: Waltham, Massachusetts
Employees: 1–10
Founded: 2011
Business Model: B2B

Website: xtuit.com
Total Funding: $22.0M
Last Round: $22.0M Series AJun 2015
Rounds: 2

About

XTuit Pharmaceuticals is an early-stage biopharmaceutical company developing therapeutics for cancer and fibrotic diseases. The company's drug development pipeline focuses on microenvironment-activated therapeutics that target the tumor microenvironment rather than the tumor itself, addressing key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response. XTuit's compounds act through pleiotropic mechanisms to inhibit extracellular matrix synthesis and stabilization and to silence activated stromal cells, including cancer-associated fibroblasts and stellate cells. XTuit raised $23.5M in funding from investors including NEA, Polaris Partners, Omega Funds, Arcus Ventures, and CTI Life Sciences Fund before being deadpooled.

Summary

Xtuit is a Biotech company based in Waltham, United States, founded in 2011. It has raised $22.0M in total across 2 rounds, most recently a $22.0M Series A round in Jun 2015. Investors include New Enterprise Associates, Polaris Partners and CTI Life Sciences Fund.